Atlas Trials

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Clinical trial NCT02972632 · COMPLETED

Trial details

NCT number
NCT02972632
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2016-12-22
Primary completion
2018-02-06
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.